Autism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
York Trials Unit, University of York, York, United Kingdom.
Front Endocrinol (Lausanne). 2023 Apr 5;14:1126023. doi: 10.3389/fendo.2023.1126023. eCollection 2023.
Levels of steroid hormones in the first three months of life, a period referred to as 'mini-puberty', are one of the earliest physiological differences between typical males and females postnatally. Autistic traits also show consistent typical sex differences in later infancy, after the 18 month of life. Previous studies have shown testosterone is associated with later levels of autistic traits. Studies testing if postnatal testosterone levels are associated with autistic traits have reported null results. No studies to date have investigated mini-puberty longitudinally or tested for interactions with baseline sex differences or familial likelihood of autism.
The 'Cambridge Human Imaging and Longitudinal Development Study' (CHILD) is a prospective enriched cohort study in Cambridge, UK. It includes physiological measurements in early infancy, as well as neurodevelopmental follow-ups over the first two years of life. A subset of the cohort also includes children with a family history of autism (a diagnosed parent or sibling). Salivary testosterone levels were assessed at two time-points, just after the 2 and 6 month of life. Autistic traits were measured using the Quantitative Checklist of Autism in Toddlers (Q-CHAT) when the children were 18 months of age.
Salivary testosterone levels were significantly higher during 'mini-puberty' in the 2 and 3 month of life, compared to after the 6 month of life, in both males and females. There was no significant sex difference at either time-point. Log-transformed testosterone levels were not associated with autistic traits (Q-CHAT). There was no interaction effect with infant sex, autism family history or baseline testosterone levels after mini-puberty (at >6 months of age).
Both male and female infants have elevated levels of salivary testosterone during mini-puberty but in this relatively small sample this was not associated with their later autistic traits at 18 months or their family history of autism. This suggests that rather than postnatal testosterone levels are more relevant for understanding the causes of autism. Future studies should test these relationships in larger samples.
生命的头三个月的类固醇激素水平,这一时期被称为“迷你青春期”,是典型的男性和女性在出生后最早的生理差异之一。自闭症特征在生命的 18 个月后,即婴儿后期也表现出一致的典型性别差异。以前的研究表明,睾丸激素与后来的自闭症特征有关。测试产后睾丸激素水平是否与自闭症特征相关的研究报告结果为零。迄今为止,没有研究从纵向角度研究迷你青春期,也没有测试其与基线性别差异或家族自闭症可能性的相互作用。
“剑桥人类成像和纵向发展研究”(CHILD)是英国剑桥的一项前瞻性富集队列研究。它包括婴儿早期的生理测量,以及生命头两年的神经发育随访。该队列的一部分还包括有自闭症家族史的儿童(诊断为父母或兄弟姐妹)。在生命的 2 个月和 6 个月后,两次评估唾液睾丸激素水平。当孩子 18 个月大时,使用自闭症幼儿定量检查表(Q-CHAT)测量自闭症特征。
与生命的 6 个月后相比,男性和女性在 2 个月和 3 个月的“迷你青春期”期间,唾液睾丸激素水平明显更高。在这两个时间点,都没有显著的性别差异。对数转换后的睾丸激素水平与自闭症特征(Q-CHAT)无关。在婴儿性别、自闭症家族史或迷你青春期后(6 个月以上)的基础睾丸激素水平方面,没有交互作用。
男性和女性婴儿在迷你青春期期间都有较高的唾液睾丸激素水平,但在这个相对较小的样本中,这与他们在 18 个月时的自闭症特征或家族自闭症史无关。这表明,产后睾丸激素水平与自闭症的原因更为相关。未来的研究应该在更大的样本中测试这些关系。